In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Baxter licenses Cerus' pathogen inactivation systems

Executive Summary

Baxter will pay upfront fees, milestones, royalties on sales, plus make an equity investment to develop with and license exclusive worldwide rights to Cerus Corp.'s fresh frozen plasma (FFP) and red blood cell pathogen inactivation systems.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register